Healthcare provider profile · identity verified

Heather Mcree, DO

Family Practice · HELENA, MT · NPI 1043299720

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	495	116
Levothyroxine Sodium	Levothyroxine Sodium	443	84
Lisinopril	Lisinopril	381	85
Omeprazole	Omeprazole	321	70
Gabapentin	Gabapentin	268	49
Amlodipine Besylate	Amlodipine Besylate	228	58
Losartan Potassium	Losartan Potassium	180	56
Metformin Hcl Er	Metformin Hcl	171	38
Duloxetine Hcl	Duloxetine Hcl	148	33
Metoprolol Succinate	Metoprolol Succinate	140	33
Alendronate Sodium	Alendronate Sodium	132	25
Hydrochlorothiazide	Hydrochlorothiazide	117	33
Albuterol Sulfate Hfa	Albuterol Sulfate	106	38
Simvastatin	Simvastatin	102	19
Potassium Chloride	Potassium Chloride	97	19
Metformin Hcl	Metformin Hcl	89	20
Celecoxib	Celecoxib	87	20
Rosuvastatin Calcium	Rosuvastatin Calcium	83	25
Escitalopram Oxalate	Escitalopram Oxalate	82	25
Trazodone Hcl	Trazodone Hcl	81	23
Metoprolol Tartrate	Metoprolol Tartrate	80	14
Sertraline Hcl	Sertraline Hcl	78	19
Bupropion Xl	Bupropion Hcl	77	20
Furosemide	Furosemide	74	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	20
Jardiance	Empagliflozin	71	11
Pantoprazole Sodium	Pantoprazole Sodium	71	suppressed
Clopidogrel	Clopidogrel Bisulfate	69	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	17
Propranolol Hcl	Propranolol Hcl	64	13
Glipizide Er	Glipizide	60	suppressed
Meloxicam	Meloxicam	59	15
Januvia	Sitagliptin Phosphate	57	suppressed
Pregabalin	Pregabalin	56	suppressed
Allopurinol	Allopurinol	54	14
Carvedilol	Carvedilol	53	18
Eliquis	Apixaban	53	12
Ozempic	Semaglutide	52	14
Tamsulosin Hcl	Tamsulosin Hcl	51	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	49	suppressed
Warfarin Sodium	Warfarin Sodium	49	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	46	suppressed
Estradiol	Estradiol	45	16
Fluticasone Propionate	Fluticasone Propionate	44	17
Spironolactone	Spironolactone	44	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	suppressed
Trulicity	Dulaglutide	39	suppressed
Aripiprazole	Aripiprazole	37	suppressed
Tradjenta	Linagliptin	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Atenolol	Atenolol	35	suppressed
Buspirone Hcl	Buspirone Hcl	35	12
Montelukast Sodium	Montelukast Sodium	35	suppressed
Finasteride	Finasteride	32	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	11
Risperidone	Risperidone	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Famotidine	Famotidine	27	suppressed
Glipizide	Glipizide	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Bupropion Hcl	Bupropion Hcl	22	suppressed
Carbamazepine Er	Carbamazepine	22	suppressed
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	12
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Prednisone	Prednisone	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Mounjaro	Tirzepatide	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Topiramate	Topiramate	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Valsartan	Valsartan	16	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	15	suppressed
Cholestyramine	Cholestyramine (With Sugar)	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Torsemide	Torsemide	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Nystatin	Nystatin	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Teriparatide	Teriparatide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error